Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC). Whether reduced-dose radiation produces disease control and QOL equivalent to standard chemoradiation is not proven. PAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Yom, Sue S., Torres-Saavedra, Pedro, Caudell, Jimmy J., Waldron, John N., Gillison, Maura L., Xia, Ping, Truong, Minh T., Kong, Christina, Jordan, Richard, Subramaniam, Rathan M., Yao, Min, Chung, Christine H., Geiger, Jessica L., Chan, Jason W., O'Sullivan, Brian, Blakaj, Dukagjin M., Mell, Loren K., Thorstad, Wade L., Jones, Christopher U., Banerjee, Robyn N., Lominska, Christopher, Le, Quynh-Thu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078254/
https://www.ncbi.nlm.nih.gov/pubmed/33507809
http://dx.doi.org/10.1200/JCO.20.03128

Ejemplares similares

Ejemplares similares